Your answers provide a snapshot of your organization’s current hemorrhage-control preparedness.
But one score cannot answer the most important question:
If severe bleeding happened right now, would the appropriate capability actually be where the casualty needs it?
The short reading below will help you understand what preparedness really means, where hidden capability gaps can occur, and what your organization may need to evaluate next.
A national agency may maintain strategic reserves. A province may hold emergency stock. A city or municipality may operate ambulances and rescue teams. A hospital may have trauma equipment ready for use.
But severe bleeding does not happen inside a preparedness plan.
And when it happens, the capability that matters most is not the equipment listed on an inventory sheet.
It is the appropriate equipment already close enough to be reached and used by a trained responder.
Owning equipment creates inventory.
Positioning it correctly, training people to use it, standardizing deployment, inspecting it, replacing it and replenishing it create capability.
That is why preparedness must extend beyond quantity.
It must reach the point of injury.
Large-scale emergencies • Surge capacity • National contingency requirements
Resources positioned closer to affected communities and response systems
Ambulances • Rescue teams • Hospitals • Health offices • Emergency operations
Medic bags • Trauma kits • Rescue packs • Operational medical kits • Trained responders
The shorter that distance becomes, the more meaningful preparedness becomes.
Severe bleeding is one of trauma care’s most time-critical emergencies.
Significant blood loss can rapidly compromise circulation and oxygen delivery to vital organs. In many emergencies, the first available responders may need to act before the casualty reaches definitive hospital care.
That is why hemorrhage-control readiness begins at the point of injury.
The response begins where the bleeding begins.
Early intervention helps preserve critical time until definitive medical treatment can be provided.
Not all traumatic bleeding presents the same anatomical challenge.
Severe bleeding involving an arm or leg may be appropriate for a conventional limb tourniquet when tourniquet use is clinically indicated and consistent with training and protocol.
Severe bleeding may also occur higher, including difficult inguinal/groin and axillary regions.
These areas are close to the torso and can create a different hemorrhage-control challenge because conventional extremity-tourniquet placement may not address the same anatomy.
Is the appropriate equipment close enough to the casualty?
Can the equipment available to the responder address the anatomical challenge they encounter?
“Will the appropriate hemorrhage-control capability be available where the emergency actually happens?”
A practical hemorrhage-control platform should help organizations strengthen several priorities at once.
Give appropriately trained responders useful options across more than one relevant hemorrhage-control scenario.
Broader capability should not automatically mean carrying multiple bulky systems.
Equipment should be practical to position in the kits, vehicles and locations where responders are most likely to need it.
Technology should complement training, protocols, medical judgment, evacuation and definitive treatment—not replace them.
That Is the Design Problem Behind the Life Saving Tourniquet.
Introducing
One Compact Platform. Two Documented Hemorrhage-Control Functions.
The Life Saving Tourniquet (LST) is a compact hemorrhage-control platform developed by TWM — Tsadik Weiser Medical Ltd., Israel, with Medspecs Solutions Inc. serving as its Philippine authorized representative and distributor.
The LST combines:
A conventional windlass-based limb-tourniquet function
A detachable pressure-pin mechanism for localized compression in appropriate difficult inguinal and axillary applications.
Its purpose is not to claim that one device can manage every bleeding emergency.
Its value lies in something more specific:
Broader hemorrhage-control capability within one compact device architecture.
The LST can be configured for appropriate conventional limb applications and, when indicated and used by trained personnel, can also employ its detachable pressure pin for selected localized junctional compression applications.
For institutions, this creates an opportunity to evaluate broader capability without automatically adding a separate full-size system for every function.
The LST weighs approximately 130 grams and uses a 155 cm strap, supporting practical deployment in environments such as IFAKs, ambulances, trauma bags, tactical medical kits, emergency carts, disaster-response caches and industrial response stations.
Its compact format is designed around a simple preparedness reality: critical equipment can only help if it is available when the responder needs it.
The LST incorporates a windlass mechanism for controlled tightening and a retention system designed to help maintain applied tension when used according to training and the manufacturer’s Instructions for Use.
Its detachable pressure pin adds a separate localized compression mechanism for selected difficult proximal applications.
A windlass-based configuration for appropriate extremity application.
The windlass allows controlled mechanical tightening, while the retention system helps secure the applied configuration during movement and transport.
The detachable pressure pin is designed to provide localized mechanical compression for appropriate difficult inguinal and axillary applications.
For familiarization only. It does not replace formal training, medical direction or the manufacturer’s current Instructions for Use.
Before an institution adopts new trauma technology, decision-makers should be able to ask:
The Life Saving Tourniquet is supported by a regulatory, technical and clinical evidence dossier developed for professional and institutional evaluation.
CDRRHR-CMDN-2026-2201221
Valid through 16 July 2031, subject to certificate conditions.
Class I Non-Pneumatic Tourniquet
These are separate regulatory pathways corresponding to the LST’s distinct documented functions.
FDA 510(k) K254060
These are separate regulatory pathways corresponding to the LST’s distinct documented functions.
The technical dossier includes updated ISO 13485:2016 quality-system certification documented as valid through 17 July 2029, subject to continued certification requirements.
In a peer-reviewed healthy-volunteer feasibility study, complete arterial occlusion was reported in:
These findings support the feasibility of short-duration arterial occlusion under controlled study conditions. They should not be interpreted as proof of mortality reduction, guaranteed effectiveness in every trauma patient, or evidence that the LST is appropriate for every hemorrhage scenario.
Assessment included palpation, pulse oximetry and Doppler criteria.
The technical dossier includes manufacturer pressure-retention testing involving eight units over a four-hour protocol.
All eight units were reported to remain above the predefined acceptance threshold throughout the test period.
This is engineering bench verification and should not be interpreted as a clinical outcome study.
Provide your medical, clinical, technical or procurement team with the available regulatory, clinical and technical documentation.
Request a QuoteResponsible medical-device evaluation requires both.
The Life Saving Tourniquet is not presented as a device for every severe bleeding injury.
It is one component within a broader trauma-response system.
Your organization may already have an established hemorrhage-control program.
That does not automatically mean your current equipment should be replaced.
Instead, evaluate your system around the questions that matter:
Tick what your current system already answers well — 0 of 6
If your existing system already answers those questions well, that is valuable.
If it does not—
That Is Where Evaluation Should Begin.
A responsible institutional pathway starts with evaluation.
Review existing equipment, deployment, training, stockpile, operational risks and potential capability gaps.
Examine intended functions, product specifications, regulatory documentation, clinical evidence, risk-benefit information, Instructions for Use and relevant limitations.
Allow appropriate stakeholders to examine the device architecture, windlass mechanism, pressure-pin configuration and intended application principles.
Where permitted by institutional policy, consider simulation, technical familiarization, selected-department review or another appropriate controlled evaluation.
Determine where capability should be positioned based on actual risk. This may include:
Determine authorized users, familiarization requirements, competency reinforcement, inspection, replacement, replenishment and protocol integration.
Only after sufficient evaluation should quantity, pricing, delivery, training requirements and commercial terms be determined.
Understand existing inventory, deployment, training, operational risk and possible capability gaps.
Provide your medical, clinical, technical or procurement team with the available regulatory, clinical and technical documentation.
Allow appropriate stakeholders to examine the device and its intended application principles.
Where institutional policy allows, explore a limited technical, simulation or operational evaluation before broader deployment.
For organizations that have completed sufficient evaluation and are ready to discuss deployment, quantity, supply and commercial requirements.
If severe hemorrhage occurred within your area of responsibility today:
If those answers are already clear, your organization has something important to build upon.
If they are not—
That Is Where the Conversation Should Begin.
From National Preparedness to Point-of-Injury Capability.
One Compact Platform. Two Distinct Hemorrhage-Control Functions.
Evidence-Led. Professionally Evaluated. Deployed Where Justified.
The Life Saving Tourniquet is intended for use by appropriately trained personnel according to the manufacturer’s current Instructions for Use, applicable clinical guidance, organizational protocols, medical direction and regulatory authorization.
No single hemorrhage-control device is appropriate for every trauma scenario. Hemorrhage-control devices do not replace emergency medical assessment, monitoring, reassessment, evacuation, resuscitation, surgery where indicated, definitive treatment or professional clinical judgment.
Product brochurePDF
Feasibility studyPDF
Label & Instructions for UsePDF